BACKGROUND/OBJECTIVES: Brief cognitive screens lack the sensitivity to detect mild cognitive impairment (MCI) or support differential diagnoses. The objective of this study was to validate the 10-minute, tablet-based University of California, San Francisco (UCSF) Brain Health Assessment (BHA) to overcome these limitations. DESIGN: Cross-sectional. SETTING: UCSF Memory and Aging Center. PARTICIPANTS: Older adults (N = 347) (neurologically healthy controls (n = 185), and individuals diagnosed with MCI (n = 99), dementia (n = 42), and as normal with concerns (n = 21)). MEASUREMENTS: The BHA includes subtests of memory, executive function and speed, visuospatial skills, and language and an optional informant survey. Participants completed the Montreal Cognitive Assessment (MoCA) and criterion-standard neuropsychological tests. Standardized structural 3T brain magnetic resonance imaging was performed in 145 participants. RESULTS: At a fixed 85% specificity rate, the BHA had 100% sensitivity to dementia and 84% to MCI; the MoCA had 75% sensitivity to dementia and 25% to MCI. The BHA had 83% sensitivity to MCI likely due to AD and 88% to MCI unlikely due to AD, and the MoCA had 58% sensitivity to MCI likely AD and 24% to MCI unlikely AD. The BHA subtests demonstrated moderate to high correlations with the criterion-standard tests from their respective cognitive domains. Memory test performance correlated with medial temporal lobe volumes; executive and speed with frontal, parietal, and basal ganglia volumes; and visuospatial with right parietal volumes.
arly, accurate diagnosis of neurocognitive disorders benefits individuals with the disorders and their families and is recommended as part of high-quality health care. 1 A diagnosis prompts an evaluation for reversible causes, guides the selection of appropriate symptomatic treatments, allows individuals and families to access supportive interventions and focuses plans for future care needs. The diagnostic process typically starts in primary care with a concern that the individual, a family member, or a clinician expresses or with a positive cognitive screen 2 and is completed in primary care or with a specialist.
Cognitive impairment and dementia are not diagnosed in more than half of cases. One barrier is the precision of brief cognitive screens used in primary care settings; although usually adequate for detecting dementia, they often fail to detect mild cognitive impairment (MCI) with high specificity. 3, 4 Most screens emphasize the detection of memory dysfunction, a hallmark of Alzheimer's disease (AD), but neglect other domains such as visuospatial and executive functions. 5 Non-AD diseases, most commonly Lewy body disease, frontotemporal lobar degeneration, and vascular disease, which frequently present with nonmemory symptoms, cause an estimated 40% to 50% of dementias. [6] [7] [8] Even AD can present with visuospatial, executive, or language dysfunction rather than memory dysfunction. 9 Cognitive screens typically rely on a single global cut-off score to determine whether an individual is impaired that may fail to detect circumscribed, nonmemory deficiencies. Furthermore, few provide a valid profile of spared and impaired cognitive domains that could be used to assist with the differential diagnosis. Also, brief screens rarely include informant surveys to evaluate functional decline and neurobehavioral changes. An ideal brain health assessment for primary care would efficiently detect all types of early decline and provide valid scores for important cognitive domains and level of functional impairment, and providers could use it, along with other clinical information, to determine whether an individual meets diagnostic criteria for common neurocognitive syndromes.
To address this need, we developed the University of California, San Francisco (UCSF) Brain Health Assessment (BHA). Subtests were designed to evaluate four cognitive domains that can be affected in neurocognitive disorders and that should be assessed using diagnostic criteria: memory, executive function and speed, visuospatial, and language. Performance is summarized across these domains, but the most affected domain also separately contributes to the determination of impairment so that individuals with a significant but circumscribed impairment are not missed. An informant survey elicits information on symptoms that are important for diagnosis, including socioemotional changes and level of functional impairment. The BHA takes 10 minutes to administer and features automated scoring and provider feedback, making it feasible to integrate into busy primary care and specialty practices.
The objectives of this study were to evaluate the BHA's accuracy in detecting mild cognitive impairment (MCI) and dementia; the concurrent validity of the newly developed subtests of memory, executive function and speed, and visuospatial skills with well-established neuropsychological tests from these domains; and the neuroanatomical validity of these subtests using voxel-based morphometry. MCI and dementia can be caused by AD as well as other diseases, and we intentionally evaluated individuals who were diverse in their underlying disease, as diagnosed by consensus case conference. This permitted sensitivity and specificity analyses separately for MCI that was likely and unlikely to be due to AD (Objective 1) and maximized sample-wide variability in brain atrophy and behavior for the validity analyses (Objectives 2 and 3). 10 
METHODS

Participants
The UCSF Committee on Human Research approved this study. All participants provided written informed consent. Participants (N = 347; neurologically healthy controls (n = 185), and individuals diagnosed with MCI (n = 99), 11 dementia (n = 42) (major neurocognitive disorder), 12 and as normal with concerns (n = 21)) were recruited from longitudinal observational studies at the UCSF Memory and Aging Center. All participants including controls were diagnosed in multidisciplinary clinical consensus conferences (Supplementary Appendix S1).
Neuropsychological Assessment
The BHA is programmed in the TabCAT software platform (UCSF, San Francisco, CA). The BHA and the Montreal Cognitive Assessment (MoCA) 13 were administered to all participants. The MoCA was selected as a criterion-standard comparison because it is a widely used screening test of similar length that has been shown to be more accurate than other widely used screening tests for the detection of MCI.
14 The BHA included four subtests. The three new subtests (Favorites (memory), Match (executive function and speed), Line Orientation (visuospatial)) are described with screenshots in Figure 1 and in detail in Supplementary Appendix S1. Animal Fluency (language), a widely used test, was also administered; subjects named different animals as quickly as they could for 1 minute.
The BHA also includes the Brain Health Survey (BHS), which an informant who knew the participant well self-administered. On each question, the informant was asked to evaluate change in the participant's functional level or emergence of new neurocognitive symptoms over the past 5 years. Twelve questions from the ECog-12 had previously been validated for the detection of MCI and dementia in a sample predominantly with AD. 15 To enhance the detection of less typical presentations, 9 additional yes-and-no questions were added to the BHS (Supplementary Appendix S2) about early neurocognitive or neurobehavioral symptoms typical of a non-AD disorder or an atypical presentation of AD.
Statistical Analyses
Sensitivity and Specificity to Dementia and MCI
Scores on the four subtests were converted to age-corrected z-scores, as described in Supplementary Appendix S1. Each participant's mean and lowest z-scores were included in the discriminant function analyses to emphasize detection of generalized cognitive impairment and domain-specific cognitive impairment when predicting a diagnosis. Recognizing that an informant is not always available in primary care settings, the discriminant function analyses were calculated with and without the informant surveys included. We discriminated a group of 137 controls from a group of participants diagnosed with dementia (n = 30) or MCI (n = 72). Next, this MCI sample was separated into two groups based on whether participants met diagnostic criteria for the categories likely due to AD (n = 29) or unlikely due to AD (n = 43). These diagnoses were made by clinical consensus conference on the basis of each participant's clinical and cognitive syndrome and structural MRI. 9 Sample details (N = 239) are provided in Supplementary  Table S1 . Receiver operating characteristic (ROC) curves were calculated for the discriminant scores for the BHA and the MoCA total. To minimize false positives, we emphasize sensitivity values at 85% specificity, which is higher than reported in many similar studies.
3,4
Concurrent Validity Analyses
Pearson correlations were computed between the three new tests (Favorites, Match, Line Orientation) and scores on widely used measures of verbal memory (California Verbal Learning Test, 2nd Edition, Long Delay Free Recall (CVLT-II Standard) or the short form (CVLT-II Short)), 16 visual memory (Benson Complex Figure Recall) 18 and visuospatial skills (Benton Judgment of Line Orientation). 19 We hypothesized that the new tests would correlate best with tests from the same domains. Sample details (n = 136) are provided in Supplementary Table S2 .
Neuroanatomical Validity Analyses
Participants underwent structural MRI scanning at the UCSF Neuroscience Imaging Center (3 Tesla TIM Trio, Siemens). We used voxel-based morphometry to determine the regional brain volumes that correlated with performance on Favorites, Match, and Line Orientation, controlling for age, sex, and total intracranial volume (Supplementary Appendix S1). Based on established brainbehavior correlates of the domains each subtest was designed to measure, we hypothesized that the Favorites test would show anatomical correlation predominantly with brain regions involved in memory functions (bilateral hippocampus), the Match test would correlate predominantly with brain regions involved in information processing speed (basal ganglia) and executive functions (i.e., dorsolateral prefrontal and parietal cortex), and the Line Orientation test would correlate predominantly with brain regions involved in dorsal-stream visuospatial processing (right parietal cortex). Sample details (n = 145) are provided in Supplementary Table S3 .
RESULTS
Sensitivity and Specificity Results
Area under the ROC curves (AUCs) were calculated to determine how well the assessments distinguished between the patient groups and controls. In distinguishing individuals with dementia from controls, the complete BHA (including the four subtests and the BHS, which comprises the ECog-12 and the additional nine questions) had an area under the ROC curve (AUC) of greater than 0.99. The AUC for the BHA cognitive tests without the BHS was nearly as high (0.95), and the AUC for the MoCA was also good (0.92). In distinguishing individuals with MCI from controls, the complete BHA had an AUC of 0.94. The BHA cognitive tests had an AUC of 0.83. Adding the ECog-12 increased the AUC to 0.89, and the additional 9 questions increased it further to 0.94. The MoCA had an AUC of 0.74. All AUC and sensitivity and specificity results to detect dementia, MCI, MCI likely due to AD, and MCI unlikely due to AD, are provided in Figure 2 .
Concurrent Validity Results
Each of the three novel BHA subtests had their highest correlation with the neuropsychological test from the same 
Neuroanatomical Validity Results
As predicted, high Favorites memory test scores correlated positively with gray matter volumes in the bilateral temporal, insular, and frontal regions (Figure 3 , Supplementary Table S5 ). The largest and most significant regional correlates were in the bilateral medial temporal lobes and a Sensitivity is provided at two levels of specificity (85%, 75%). b BHA: Complete comprised the subtests (operationalized using mean and lowest age-corrected z-score) and the Brain Health Survey informant survey (ECog-12 and additional nine questions). SN = sensitivity; MCI = mild cognitive impairment.
included the full extent of the right and left hippocampi, entorhinal cortices, and amygdalae. High scores on the Match executive function and speed test correlated positively with gray matter volumes predominantly in the right and left lateral frontal, parietal, and subcortical regions (caudate, putamen, thalamus). Low Line Orientation visuospatial test scores correlated positively with gray matter volumes in a cluster located in the right parietal lobe, specifically involving the right postcentral gyrus, right supramarginal gyrus, and right superior parietal lobule. All reported results were significant after family-wise error (FWE) correction at P FWE <.05.
DISCUSSION
There is a significant need for efficient and accurate detection and diagnosis of early neurocognitive changes in primary care settings. The BHA had 84% sensitivity to detect MCI and 100% sensitivity to detect dementia at 85% specificity, and the new BHA subtests produced valid cognitive domain subscores. Although the BHA and the MoCA accurately detected dementia, the BHA detected MCI more accurately. This finding was most evident in individuals diagnosed with MCI that was unlikely to be due to AD, in whom the BHA had a sensitivity of 88%, whereas the MoCA had a sensitivity of 24% at 85% specificity. The three novel subtests of memory (Favorites), executive function and speed (Match), and visuospatial skills (Line Orientation) were found to be valid measures of the cognitive constructs they were designed to measure. Each of these subtests had moderate to high correlations with established tests from the same cognitive domains and lower correlations with other domains. Each subtest also correlated with regional brain volumes in predicted patterns; Favorites correlated with brain regions important for memory, including the medial temporal lobes 20 ; Match correlated with brain regions important for executive functions and speed in the dorsal frontoparietal network and basal ganglia 21 ; and Line Orientation correlated with a cluster in the right parietal lobe. 22 The remaining BHA cognitive subtest, Animal Fluency (widely used to assess the language domain), is sensitive to temporal and frontal lobe pathologies. 23 Fewer than half of individuals with positive cognitive screening test results in primary care undergo any further diagnostic assessments. System-level barriers that probably contribute to this gap include unavailability of specialists. 2 Supporting primary care practitioners in performing the necessary testing and diagnostic evaluations for uncomplicated patients could lower this barrier. This is particularly crucial in rural areas, where access to specialist services is often reduced. 24 The BHA provides valid subscores in domains of cognition and function that are important for diagnosis of MCI 11 and dementia 12 and that could improve diagnostic capability in the primary care setting by satisfying criteria for common neurocognitive syndromes, including typical and atypical AD, 9 Lewy body dementia, 25 and frontotemporal dementia.
26,27
The BHS informant survey, comprising the ECog-12 and 9 additional questions, substantially increased the sensitivity to detect MCI beyond the cognitive subtests. Adding the ECog-12 increased sensitivity from 72% to 82% to detect MCI that was likely to be due to AD, with specificity fixed at 85%. This finding is consistent with previous work showing that the full-length version of this measure, independent of neuropsychological test performance, aids in predicting who will develop MCI, dementia, and disability. 28, 29 The additional 9 questions, designed to elicit symptoms of less typical presentations of AD and non-AD disorders, increased the sensitivity minimally beyond the ECog-12 in this group that was likely to have AD (83%). In individuals with MCI diagnosed as unlikely to be due to AD, the ECog-12 increased sensitivity from 54% to 70%, the additional 9 questions increased it further to 88%. The BHS increased the sensitivity to dementia minimally from 95% to more than 99%. In sum, the quick informant surveys improved MCI detection rates substantially but were less important when an individual had progressed to dementia. The additional BHS questions enhanced the ability to identify less typical AD or non-AD presentations, and more work is needed to understand their added value in real-world primary care samples. The informant self-administers these surveys on paper or an electronic tablet using a simple response format, which may be convenient for implementation in busy primary care practices.
Additional work is underway to ensure that the BHA is ready for translation into real-world primary care settings. The study sample was English speaking and had moderate to high levels of education. Careful attention was paid during the BHA development to choose stimuli that are culturally fair, including ethnically diverse face stimuli, to reduce cultural bias, but broad utility cannot be assumed, and we are evaluating the validity of the translated and culturally adapted versions of the BHA in less educated and culturally diverse populations. In primary care implementation studies, we plan to evaluate the BHA's utility in individuals with MCI, who will on average be older and have more medical comorbidities and a lower proportion of atypical causes of dementia. The BHA cannot be self-administered; some interaction with clinical staff and a quiet space are required, which may be an obstacle for some practices. The BHA's brevity, automated scoring, sensitivity, specificity, and minimal training requirements for clinical staff are attributes that may contribute to its adoption in the primary care setting.
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